. . . . . . . . . . . . . . . . "a(CHEBI:cisplatin) -| kin(p(HGNC:CDK2))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "To directly measure cdk2 activity after cisplatin treatment, immunoprecipitated cdk2 kinase assays were performed. Consistent with the levels of pTyr15-cdk2 after cisplatin treatment in the absence of doxycycline, there was a 2.5-fold reduction in cdk2 kinase activity." . . "Selventa" . . . . "2014-07-03T14:33:36.118+02:00"^^ . . .